BlackRock’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.83M Buy
5,514,879
+4,153,842
+305% +$5.9M ﹤0.01% 3489
2025
Q1
$2.08M Buy
1,361,037
+103,258
+8% +$158K ﹤0.01% 3941
2024
Q4
$3.12M Sell
1,257,779
-454,018
-27% -$1.13M ﹤0.01% 3855
2024
Q3
$1.97M Sell
1,711,797
-320,358
-16% -$368K ﹤0.01% 3954
2024
Q2
$2.24M Sell
2,032,155
-3,169,992
-61% -$3.49M ﹤0.01% 3886
2024
Q1
$6.45M Sell
5,202,147
-703,725
-12% -$873K ﹤0.01% 3511
2023
Q4
$6.2M Buy
5,905,872
+297,982
+5% +$313K ﹤0.01% 3531
2023
Q3
$38.4M Buy
5,607,890
+13,717
+0.2% +$94K ﹤0.01% 2520
2023
Q2
$58M Buy
5,594,173
+478,800
+9% +$4.97M ﹤0.01% 2351
2023
Q1
$41.4M Buy
5,115,373
+26,714
+0.5% +$216K ﹤0.01% 2536
2022
Q4
$80.1M Buy
5,088,659
+278,361
+6% +$4.38M ﹤0.01% 2140
2022
Q3
$75.7M Buy
4,810,298
+140,382
+3% +$2.21M ﹤0.01% 2123
2022
Q2
$65.2M Buy
4,669,916
+682,809
+17% +$9.53M ﹤0.01% 2284
2022
Q1
$68.7M Sell
3,987,107
-91,768
-2% -$1.58M ﹤0.01% 2350
2021
Q4
$59.3M Buy
4,078,875
+290,458
+8% +$4.22M ﹤0.01% 2505
2021
Q3
$68.2M Buy
3,788,417
+549,368
+17% +$9.89M ﹤0.01% 2424
2021
Q2
$56.9M Buy
3,239,049
+2,254,173
+229% +$39.6M ﹤0.01% 2573
2021
Q1
$24.8M Buy
984,876
+11,706
+1% +$295K ﹤0.01% 3016
2020
Q4
$6.3M Sell
973,170
-67,200
-6% -$435K ﹤0.01% 3533
2020
Q3
$2.67M Sell
1,040,370
-7,446
-0.7% -$19.1K ﹤0.01% 3724
2020
Q2
$1.7M Sell
1,047,816
-1,578,705
-60% -$2.56M ﹤0.01% 3792
2020
Q1
$2.73M Sell
2,626,521
-13,048
-0.5% -$13.6K ﹤0.01% 3501
2019
Q4
$4.99M Sell
2,639,569
-392,200
-13% -$741K ﹤0.01% 3450
2019
Q3
$3.28M Buy
3,031,769
+48,660
+2% +$52.6K ﹤0.01% 3560
2019
Q2
$6.53M Sell
2,983,109
-149,824
-5% -$328K ﹤0.01% 3401
2019
Q1
$18.8M Sell
3,132,933
-487,902
-13% -$2.92M ﹤0.01% 2760
2018
Q4
$26.8M Buy
3,620,835
+1,103,423
+44% +$8.15M ﹤0.01% 2561
2018
Q3
$36.6M Buy
2,517,412
+205,771
+9% +$2.99M ﹤0.01% 2532
2018
Q2
$46.2M Buy
2,311,641
+204,215
+10% +$4.08M ﹤0.01% 2386
2018
Q1
$36.9M Sell
2,107,426
-87,602
-4% -$1.53M ﹤0.01% 2432
2017
Q4
$54.1M Buy
2,195,028
+485,146
+28% +$12M ﹤0.01% 2228
2017
Q3
$44.1M Buy
1,709,882
+510,356
+43% +$13.2M ﹤0.01% 2341
2017
Q2
$32.5M Buy
1,199,526
+418,483
+54% +$11.3M ﹤0.01% 2481
2017
Q1
$23.3M Buy
781,043
+780,343
+111,478% +$23.3M ﹤0.01% 2642
2016
Q4
$19K Buy
700
+200
+40% +$5.43K ﹤0.01% 3202
2016
Q3
$13K Sell
500
-349
-41% -$9.07K ﹤0.01% 3293
2016
Q2
$16K Buy
849
+500
+143% +$9.42K ﹤0.01% 3280
2016
Q1
$7K Buy
+349
New +$7K ﹤0.01% 3208